Study analysis · Nutrition Journal · 2024
The protein paradox: Eating too little may raise death risk in older adults—but eating more may be harmful if you're under 65.
A large 15-year study found that people who ate the least protein building blocks had a modestly higher relative risk of dying, but the effect vanished when early deaths were removed, so it's not proof that low protein is the cause.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
In simple terms
This study followed a large group of people for many years to see if what they ate was linked to how long they lived. It can show that certain eating habits go together with higher or lower death rates, but it cannot prove that the amino acids themselves caused those deaths.
What’s the bottom line?
In a large Iranian study, people who ate the least amino acids had slightly higher death rates over 15 years, but the pattern was not simple and depended on age.
How strong is this study?
The study is strong because it included many people and followed them for a long time. But people had to remember and report what they ate, which isn't always accurate, and other lifestyle factors could explain the results, so we should be careful about trusting the exact numbers.
40 / 100
- COI disclosure+40/40
- Data availabilitydata not shared
- Code availabilitycode not shared
56 / 100
- Randomizationnot randomized
- Blindingblinding unclear
- Control group+15/15
- Sample size (n=47337)+20/20
- Follow-up+10/10
100 / 100
77 / 100
- P-values+15/15
- Effect size+20/20
- Confidence intervals+15/15
- Pre-registrationnot pre-registered
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 567 / 100
Probability of being correct
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
This design cannot establish causation — the findings describe an association, not a cause. Observational cohort design without randomization. Confounding by socioeconomic, lifestyle, and dietary factors cannot be fully controlled. Dietary exposure measured by self-reported FFQ at baseline only, leading to measurement error and potential reverse causation. Therefore, this study cannot prove cause-effect relationships.
No Conflicts
No conflicts of interest identified
No conflicts of interest or funding statements were included in the provided text; no author disclosures or industry ties are apparent.
The provided text lacks a competing interests or funding section. Ethical approval from DDRC, NCI, and WHO IARC is noted, but their funding role is unspecified. No author affiliations or industry employment are disclosed.
Key takeaways
- 01
Compared to middle intake, lowest intake of essential amino acids was linked to 16% higher relative risk of death (HR 1.16).
- 02
For cardiovascular death, the relative risk was 23% higher (HR 1.23).
- 03
Overall, 9,231 of 47,337 people died (about 19.5% absolute risk over 15 years).
- 04
The absolute risk increase for low intake was not reported.
- 05
The overall absolute risk of death was about 20% over 15 years.
- 06
The study did not report how much the absolute risk increased specifically for the lowest-intake group.
- 07
A 16% relative increase would be modest in absolute terms if the baseline risk is around 20%, but the exact number of extra deaths per 1,000 people is not given.
- 08
Also, the link disappeared when the first 2 years were excluded, suggesting reverse causation.
Surprising findings
- The effect of amino acid intake on mortality flips depending on age: high intake was detrimental in middle-aged adults, while low intake was detrimental in older adults.Most nutrition advice treats protein as universally good or bad. This suggests the optimal direction may reverse with age, contradicting simple 'more protein is better' or 'less protein is better' narratives.
- The main associations disappeared in the 2-year lag analysis, suggesting reverse causation.The headline result—low amino acids linked to higher death risk—was not robust to excluding early deaths. This means early illness may have caused both lower intake and higher mortality.
- High intake of proline and glycine was associated with higher mortality, while low intake of most other amino acids was linked to higher mortality.Proline and glycine are often marketed for skin, joints, and sleep. This study found high proline linked to higher all-cause mortality and high glycine linked to higher cardiovascular mortality.
- Low intake of almost every individual amino acid was linked to higher mortality—except lysine.Lysine is an essential amino acid, so you might expect low intake to be harmful. The fact that it was the exception suggests the relationships are more complex than simply 'essential amino acids are good.'
- Plant protein's health benefits may not be due to its amino acid composition.Many people assume plant protein is healthier because of its amino acid profile. The authors suggest other components in plant foods may be responsible.
Practical takeaways
If you are over 65, make sure you are eating adequate protein and amino acids from whole foods to support muscle, immune function, and longevity.
This is observational, and the absolute risk increase was not reported. The 2-year lag analysis was null, so causality is uncertain. Do not change medications or diet drastically without medical advice.
medium confidenceIf you are middle-aged (under 65), avoid excessive protein or amino acid intake, especially from supplements, until more research clarifies the risks.
The study did not prove that high protein causes harm in middle-aged adults. The association was non-linear and could be confounded by other lifestyle factors.
low confidenceDo not rely on BCAA, proline, or glycine supplements for longevity based on this study.
The study measured dietary intake, not supplements. High proline and glycine were linked to higher mortality, but these are observational associations, not proof of harm.
low confidenceFocus on overall diet quality and whole protein sources rather than obsessing over individual amino acids.
The study did not test whole-food diets directly. The authors suggest plant protein benefits may come from other components, not amino acids.
medium confidenceWhen reading nutrition headlines, always ask for the absolute risk difference, not just the relative risk.
This study did not report absolute risk increases for low amino acid intake. The overall absolute mortality was about 19.5% over 15 years, which can help contextualize relative risks.
high confidenceWhy this study matters
Low amino acid intake linked to higher mortality—but absolute risk is missing
In 47,337 Iranian adults followed for a median of 15 years, the lowest vs. middle quintile of essential amino acids was associated with a 16% higher relative risk of all-cause mortality (HR 1.16, 95% CI 1.07–1.26) and a 23% higher relative risk of cardiovascular mortality (HR 1.23, 95% CI 1.09–1.38). Overall absolute mortality was 9,231/47,337 ≈ 19.5% over 15 years, but the study did not report the absolute risk increase for low intake. If the reference risk were around 20%, a 16% relative increase would be roughly 3.2 percentage points, or about 32 extra deaths per 1,000 people over 15 years—but this is a rough derivation, not a reported result.
Headlines often say 'low protein linked to death' without clarifying that relative risk can sound scary while the absolute extra risk may be modest. This study gives a perfect teaching moment for relative vs. absolute risk.
Age flips the effect: high intake harmful under 65, low intake harmful over 65
The study found a statistically significant age interaction (P for interaction <0.05). In middle-aged adults (<65 years), higher amino acid intake was associated with increased mortality risk. In older adults (≥65 years), lower amino acid intake was associated with increased mortality risk. The abstract states: 'While high amino acid diets were detrimental in middle-aged adults (<65 years), increased hazards of mortality were observed among older adults (≥65 years) with low amino acid intake.'
This directly challenges one-size-fits-all protein advice. It suggests that the optimal amount of protein may depend on your age—more may be better for older adults, but not necessarily for the middle-aged.
The 2-year lag null: a major reverse-causation red flag
When researchers excluded deaths and cancer diagnoses within the first two years of follow-up, the associations between amino acid intake and mortality were no longer statistically significant. The study states: 'In the two-year lag analysis, the risk of all-cause and cause-specific mortality did not differ significantly among the extreme quintiles of amino acids consumption.' This suggests that early undiagnosed illness may have lowered people's appetite and amino acid intake, creating a false link.
It shows why observational nutrition studies must be interpreted cautiously. A finding can look strong until you account for reverse causation.
Not all amino acids behave the same: low lysine is an exception, high proline and glycine may be harmful
Low intake (first quintile) of most individual amino acids was associated with about 12–18% higher relative risk of all-cause mortality compared with the middle quintile—except for lysine. At the same time, high intake of proline was associated with an 11% higher relative risk of all-cause mortality (HR 1.11, 95% CI 1.01–1.22), and high intake of glycine was associated with a 13% higher relative risk of cardiovascular mortality (HR 1.13, 95% CI 1.00–1.29).
It busts the idea that all amino acids are interchangeable. Some may be protective at low levels, while others might be harmful at high levels—especially relevant for supplement marketing.
Plant protein benefits may not be about amino acids
The discussion notes that plant-based proteins contain relatively high non-essential amino acids and low essential amino acids compared with animal proteins. Yet plant protein has been linked to better health outcomes. The authors suggest: 'Our data suggest that the beneficial effects of plant-based protein might not be related to their amino acid contents and attract the attention to the other components related to protein-rich foods,' such as antioxidants, fiber, minerals, and phenolic compounds.
Many people choose plant protein for its amino acid profile. This study hints that the benefits may come from other components, not the amino acids themselves.
Non-linear, U-shaped patterns: more is not always better
The study found non-linear associations between amino acid intake and mortality, with the middle quintile as reference. For essential amino acids, the dose-response curve was 'slightly U-shaped.' High intake was generally not associated with increased risk after full adjustment, except for proline and glycine. Low intake was more consistently associated with higher mortality.
It supports a 'Goldilocks' view of protein: too little may be harmful, but too much may not be beneficial either—and for some amino acids, it may be harmful.
Want the whole report?
Detailed mode opens the full scientific breakdown — every score component, the methodology, conflicts of interest, the evidence analysis behind each claim, and the raw study data.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
In a large Iranian study, people who ate the least amino acids had slightly higher death rates over 15 years, but the pattern was not simple and depended on age.
Research results
Compared to middle intake, lowest intake of essential amino acids was linked to 16% higher relative risk of death (HR 1.16). For cardiovascular death, the relative risk was 23% higher (HR 1.23). Overall, 9,231 of 47,337 people died (about 19.5% absolute risk over 15 years). The absolute risk increase for low intake was not reported.
What this means - more context
The overall absolute risk of death was about 20% over 15 years. The study did not report how much the absolute risk increased specifically for the lowest-intake group. A 16% relative increase would be modest in absolute terms if the baseline risk is around 20%, but the exact number of extra deaths per 1,000 people is not given. Also, the link disappeared when the first 2 years were excluded, suggesting reverse causation.
To evaluate associations between dietary amino acid composition (essential, non-essential, branched-chain, aromatic, sulfur-containing) and all-cause and cause-specific mortality in Iranian adults.
In the Golestan Cohort Study of 47,337 Iranian adults aged 40–75, followed for a median of 15 years, dietary amino acid intake showed non-linear associations with mortality. Compared with the middle quintile, the lowest quintile of most amino acid groups was associated with 12–28% higher relative risks of all-cause, cardiovascular, cancer, or other mortality, while high intake was generally not associated with increased risk after full adjustment. The absolute risk increase for low intake was not reported. Overall, 9,231 deaths occurred (about 19.5% absolute mortality over 15 years). Associations were modified by age and were not significant after excluding the first two years of follow-up.
Methods Used
Prospective cohort study; 47,337 participants from the Golestan Cohort Study in Iran; baseline validated 116-item food frequency questionnaire; Cox proportional hazards regression by quintiles of amino acid intake with the third quintile as reference; median 15-year follow-up; 9,231 deaths documented.
Main Finding
Low intake (first quintile vs. third quintile) of essential amino acids was associated with a 16% higher relative risk of all-cause mortality (HR 1.16, 95% CI 1.07–1.26) and a 23% higher relative risk of cardiovascular mortality (HR 1.23, 95% CI 1.09–1.38). Similar non-linear patterns were seen for non-essential amino acids, BCAAs, AAAs, and SAAs. The absolute risk increase was not reported in this study. Overall absolute mortality was 9,231/47,337 ≈ 19.5% over a median of 15 years. Age interaction: high amino acid intake was detrimental in adults <65 years, while low intake was detrimental in adults ≥65 years. A 2-year lag analysis showed no significant associations.
Confidence Level
Moderate; large prospective cohort with long follow-up and detailed adjustment, but dietary intake was self-reported at baseline only, residual confounding is possible, and the null 2-year lag analysis suggests potential reverse causation.
Study Flags
Red Flags
- •Self-reported food frequency questionnaire and single baseline diet measurement
- •Associations null in 2-year lag analysis, suggesting possible reverse causation
- •Residual confounding and limited generalizability to other populations
No biological mechanisms were identified in this study. This may be an epidemiological, observational, or survey-based study that reports associations rather than proposing causal biological pathways.
Surprising Findings
The effect of amino acid intake on mortality flips depending on age: high intake was detrimental in middle-aged adults, while low intake was detrimental in older adults.
Most nutrition advice treats protein as universally good or bad. This suggests the optimal direction may reverse with age, contradicting simple 'more protein is better' or 'less protein is better' narratives.
Practical Takeaways
If you are over 65, make sure you are eating adequate protein and amino acids from whole foods to support muscle, immune function, and longevity.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 567 / 100
Probability of being correct
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
Human Cohort Study
Subject
Moderate probability
on the GRADE evidence scale
This study followed a large group of people for many years to see if what they ate was linked to how long they lived. It can show that certain eating habits go together with higher or lower death rates, but it cannot prove that the amino acids themselves caused those deaths.
The study has a COI section but no disclosure was found. A small penalty has been applied.
Strengths
- Large prospective cohort (47,337 participants).
- Long median follow-up (15 years) with 9,231 deaths.
- Cause-specific mortality ascertained via verbal autopsy and medical records.
Weaknesses
- Observational design; no randomization.
- Self-reported dietary intake via FFQ; measurement error and recall bias.
- Single baseline diet assessment; cannot capture dietary changes.
Methodology
Evidence Keywords
Statistical Reporting
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
In a large Iranian study, people who ate the least amino acids had slightly higher death rates over 15 years, but the pattern was not simple and depended on age.
Research results
Compared to middle intake, lowest intake of essential amino acids was linked to 16% higher relative risk of death (HR 1.16). For cardiovascular death, the relative risk was 23% higher (HR 1.23). Overall, 9,231 of 47,337 people died (about 19.5% absolute risk over 15 years). The absolute risk increase for low intake was not reported.
What this means - more context
The overall absolute risk of death was about 20% over 15 years. The study did not report how much the absolute risk increased specifically for the lowest-intake group. A 16% relative increase would be modest in absolute terms if the baseline risk is around 20%, but the exact number of extra deaths per 1,000 people is not given. Also, the link disappeared when the first 2 years were excluded, suggesting reverse causation.
To evaluate associations between dietary amino acid composition (essential, non-essential, branched-chain, aromatic, sulfur-containing) and all-cause and cause-specific mortality in Iranian adults.
In the Golestan Cohort Study of 47,337 Iranian adults aged 40–75, followed for a median of 15 years, dietary amino acid intake showed non-linear associations with mortality. Compared with the middle quintile, the lowest quintile of most amino acid groups was associated with 12–28% higher relative risks of all-cause, cardiovascular, cancer, or other mortality, while high intake was generally not associated with increased risk after full adjustment. The absolute risk increase for low intake was not reported. Overall, 9,231 deaths occurred (about 19.5% absolute mortality over 15 years). Associations were modified by age and were not significant after excluding the first two years of follow-up.
Methods Used
Prospective cohort study; 47,337 participants from the Golestan Cohort Study in Iran; baseline validated 116-item food frequency questionnaire; Cox proportional hazards regression by quintiles of amino acid intake with the third quintile as reference; median 15-year follow-up; 9,231 deaths documented.
Main Finding
Low intake (first quintile vs. third quintile) of essential amino acids was associated with a 16% higher relative risk of all-cause mortality (HR 1.16, 95% CI 1.07–1.26) and a 23% higher relative risk of cardiovascular mortality (HR 1.23, 95% CI 1.09–1.38). Similar non-linear patterns were seen for non-essential amino acids, BCAAs, AAAs, and SAAs. The absolute risk increase was not reported in this study. Overall absolute mortality was 9,231/47,337 ≈ 19.5% over a median of 15 years. Age interaction: high amino acid intake was detrimental in adults <65 years, while low intake was detrimental in adults ≥65 years. A 2-year lag analysis showed no significant associations.
Confidence Level
Moderate; large prospective cohort with long follow-up and detailed adjustment, but dietary intake was self-reported at baseline only, residual confounding is possible, and the null 2-year lag analysis suggests potential reverse causation.
Study Flags
Red Flags
- •Self-reported food frequency questionnaire and single baseline diet measurement
- •Associations null in 2-year lag analysis, suggesting possible reverse causation
- •Residual confounding and limited generalizability to other populations
No biological mechanisms were identified in this study. This may be an epidemiological, observational, or survey-based study that reports associations rather than proposing causal biological pathways.
Surprising Findings
The effect of amino acid intake on mortality flips depending on age: high intake was detrimental in middle-aged adults, while low intake was detrimental in older adults.
Most nutrition advice treats protein as universally good or bad. This suggests the optimal direction may reverse with age, contradicting simple 'more protein is better' or 'less protein is better' narratives.
Practical Takeaways
If you are over 65, make sure you are eating adequate protein and amino acids from whole foods to support muscle, immune function, and longevity.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 567 / 100
Probability of being correct
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
Human Cohort Study
Subject
Moderate probability
on the GRADE evidence scale
This study followed a large group of people for many years to see if what they ate was linked to how long they lived. It can show that certain eating habits go together with higher or lower death rates, but it cannot prove that the amino acids themselves caused those deaths.
The study has a COI section but no disclosure was found. A small penalty has been applied.
Strengths
- Large prospective cohort (47,337 participants).
- Long median follow-up (15 years) with 9,231 deaths.
- Cause-specific mortality ascertained via verbal autopsy and medical records.
Weaknesses
- Observational design; no randomization.
- Self-reported dietary intake via FFQ; measurement error and recall bias.
- Single baseline diet assessment; cannot capture dietary changes.
Methodology
Evidence Keywords
Statistical Reporting
Scoring
How strong is this study?
The study is strong because it included many people and followed them for a long time. But people had to remember and report what they ate, which isn't always accurate, and other lifestyle factors could explain the results, so we should be careful about trusting the exact numbers.
40 / 100
- COI disclosure+40/40
- Data availabilitydata not shared
- Code availabilitycode not shared
56 / 100
- Randomizationnot randomized
- Blindingblinding unclear
- Control group+15/15
- Sample size (n=47337)+20/20
- Follow-up+10/10
100 / 100
77 / 100
- P-values+15/15
- Effect size+20/20
- Confidence intervals+15/15
- Pre-registrationnot pre-registered
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 567 / 100
Probability of being correct
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
This design cannot establish causation — the findings describe an association, not a cause. Observational cohort design without randomization. Confounding by socioeconomic, lifestyle, and dietary factors cannot be fully controlled. Dietary exposure measured by self-reported FFQ at baseline only, leading to measurement error and potential reverse causation. Therefore, this study cannot prove cause-effect relationships.
No Conflicts
No conflicts of interest identified
No conflicts of interest or funding statements were included in the provided text; no author disclosures or industry ties are apparent.
The provided text lacks a competing interests or funding section. Ethical approval from DDRC, NCI, and WHO IARC is noted, but their funding role is unspecified. No author affiliations or industry employment are disclosed.
Standing
The people behind it
The researchers who wrote the study this analysis is built on.
Authored by
11 researchersIf this is your work, this is how we attribute it on Fit Body Science. Asieh Mansour is listed as the lead author.
- Azita HekmatdoostCorrespondingNational Nutrition and Food Technology Research Institute